Anders Kjellberg

Has grant

Karolinska University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Kan vi bota långvariga besvär efter COVID-19 med hyperbar oxygen (HBO): En randomiserad placebokontrollerad läkemedelsprövning.

Open Date: 2021-01-01

Close Date: 2021-12-31

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

Kenny A. Rodriguez-Wallberg

Karolinska Institutet

SWEDEN

View details

Helena Bergsten

Karolinska Institutet

SWEDEN

View details

Michael Pawlik

Head, Chief of Department

Caritas Clinic St. Josef Regensburg

GERMANY

View details

Malene Lindholm

Karolinska Institutet

SWEDEN

View details

Sergiu Catrina

Karolinska University Hospital

SWEDEN

View details

Otto Ettala

Helsinki University Hospital

FINLAND

View details

Peter Lindholm

Professor

UCSD

UNITED STATES

View details

Xiaowei Zheng

Karolinska University Hospital

SWEDEN

View details

Malin Nygren-Bonnier

Karolinska University Hospital

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anders Kjellberg

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (20)

Use of Hyperbaric Oxygen in Patients with Necrotizing Soft Tissue Infections: A Scandinavian Multicenter, Prospective, Observational Cohort.

Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): long-term follow-up of a randomised controlled, phase 2–3 trial

Ten sessions of hyperbaric oxygen versus sham treatment in patients with long covid (HOT-LoCO): a randomised, placebo-controlled, double-blind, phase II trial

A novel treatment strategy with hyperbaric oxygen of chronic osteomyelitis and pseudoarthrosis in a child with congenital hereditary sensory and autonomic neuropathy type 4 congenital insensitivity to pain with anhidrosis syndrome: a case report

Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: A randomised, open label, phase II trial

Contemporary national outcomes of hyperbaric oxygen therapy in necrotizing soft tissue infections

Hyperbaric oxygen therapy as an immunomodulatory intervention in COVID-19-induced ARDS: Exploring clinical outcomes and transcriptomic signatures in a randomised controlled trial

Is there a rationale for hyperbaric oxygen therapy in the patients with Post COVID syndrome? : A critical review.

COVID-19-Induced Acute Respiratory Distress Syndrome Treated with Hyperbaric Oxygen: Interim Safety Report from a Randomized Clinical Trial (COVID-19-HBO)

Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial

Comparing the Blood Response to Hyperbaric Oxygen with High-Intensity Interval Training—A Crossover Study in Healthy Volunteers

Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial

Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial

Lemierre’s syndrome caused by Fusobacterium necrophorum complicated with multiple brain abscesses—A case report, literature review, and suggested management

Lemierre's syndrome caused by Fusobacterium necrophorum complicated with multiple brain abscesses-A case report, literature review, and suggested management

Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19

Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19

Correlation Between Immunoglobulin Dose Administered and Plasma Neutralization of Streptococcal Superantigens in Patients With Necrotizing Soft Tissue Infections.

Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19?

Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19?

Collaborators (9)

Kenny A. Rodriguez-Wallberg

Helena Bergsten

Michael Pawlik

Malene Lindholm

Sergiu Catrina

Otto Ettala

Peter Lindholm

Xiaowei Zheng

Malin Nygren-Bonnier

Make your next move.